Modulations of breast fibroblast and carcinoma cell interactions by a dextran derivative (CMDB7)

Anticancer Res. 1997 Jan-Feb;17(1A):253-8.

Abstract

Modulation of interactions between human breast carcinoma cells (MCF-7ras) and fibroblasts from normal breast tissue (MG3) and from a post-radiation fibrosis with recurrent breast carcinoma (FPR7) by a dextran derivative (CMDB7) was investigated. In a coculture system, MCF-7ras proliferation was increased (50%) by fibroblasts, and fibroblasts showed a 84% growth increase with MCF-7ras. This co-stimulation did not depend on fibroblast origin. CMDB7 can inhibit the growth of MCF-7ras but not the growth of fibroblasts. The addition of CMDB7 blocks the MCF-7ras stimulation by fibroblasts but not the fibroblast stimulation by MCF-7ras. Fibroblast-Conditioned Medium stimulated over 2-3 fold MCF-7ras's DNA synthesis but CMDB7 did not influence this paracrine stimulation. IGFI, IGFII stimulated MCF-7ras's DNA synthesis whereas bFGF inhibited it. CMDB7 did not block IGFI and IGFII's stimulatory effects but increased bFGF's inhibitory effects. These results indicate that CMDB7 can inhibit fibroblast-breast cancer cell interactions possibly by interfering with paracrine growth factor loops.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Breast Neoplasms / pathology*
  • Cell Communication / drug effects*
  • Cell Division / drug effects
  • Coculture Techniques
  • Dextrans / pharmacology*
  • Female
  • Fibroblast Growth Factor 2 / pharmacology
  • Fibroblasts / pathology
  • Humans
  • Tumor Cells, Cultured

Substances

  • Dextrans
  • Fibroblast Growth Factor 2